Business Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the company, compounded GLP-1 drugs and AI. Read the original report. Share on Facebook Share on Twitter Share on Pinterest Share on LinkedIn Articles You May Like Prediction market traders see roughly 1-in-4 odds Paramount’s bid to buy Warner Bros. Discovery fails Group including Jeff Bezos buys minority stake in Liverpool FC, with option to become controlling owner Lakers governor Jeanie Buss says siblings cannot sell family’s stake to Bob Iger, Joshua Kushner Home sellers start getting lower prices at 70, research shows — and the gap widens with age Boom in tech wealth is fueling record prices for dinosaur bones, art and watches, auction houses say